PK-Directed Intravenous Busulfan in Combination with High-Dose Melphalan and Bortezomib As Conditioning Regimen for Patients with Multiple Myeloma

被引：1
|
作者：
Barta, Stefan Klaus [1 ]
Mazumder, Amitabha [2 ]
Carter, Jason [1 ]
Almanzar, Lawrence [1 ]
Elkind, Richard [1 ]
Battini, Ramakrishna [1 ]
Derman, Olga [1 ]
Kornblum, Noah [1 ]
Xue, Xionan [3 ]
Verma, Amit [1 ]
Braunschweig, Ira [1 ]
机构：
[1] Montefiore Med Ctr, Bronx, NY 10467 USA
[2] NYU Canc Ctr, New York, NY USA
[3] Albert Einstein Canc Ctr, Bronx, NY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2013.12.146
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
126
引用
收藏
页码：S104 / S105
页数：2
相关论文
共 50 条
  • [1] PK-Directed Intravenous Busulfan In Combination With High-Dose Melphalan and Bortezomib As Conditioning Regimen For Patients With Multiple Myeloma
    Barta, Stefan K.
    Mazumder, Amitabha
    Carter, Jason
    Almanzar, Lawrence
    Elkind, Richard
    Battini, Ramakrishna
    Derman, Olga
    Kornblum, Noah
    Xue, Xiaonan
    Verma, Amit
    Braunschweig, Ira
    BLOOD, 2013, 122 (21)
  • [2] Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma
    Barta, Stefan K.
    Jain, Rishi
    Mazumder, Amithaba
    Carter, Jason
    Almanzar, Lawrence
    Browne, Roy
    Shahnaz, Samira
    Elkind, Richard
    Kaminetzky, David
    Battini, Ramakrishna
    Derman, Olga
    Kornblum, Noah
    Verma, Amit
    Braunschweig, Ira
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10) : 650 - 657
  • [3] Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Rodriguez, Tulio E.
    Hari, Parameswaran
    Stiff, Patrick J.
    Smith, Scott E.
    Sterrenberg, Danielle
    Vesole, David H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1391 - 1396
  • [4] Busulfan and melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Jin Seok
    Min, Chang-Ki
    Kim, Kihyun
    Choi, Yunsuk
    Eom, Hyeon-Seok
    Joo, Young Don
    Kim, Sung-Hyun
    Kwak, Jae-Yong
    Kang, Hye Jin
    Lee, Jae Hoon
    Lee, Ho Sup
    Mun, Yeung-Chul
    Moon, Joon Ho
    Sohn, Sang Kyun
    Park, Seong Kyu
    Park, Yong
    Shin, Ho-Jin
    Yoon, Sung-Soo
    BONE MARROW TRANSPLANTATION, 2018, 53 : 262 - 263
  • [5] Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma
    Blanes, M.
    Lorenzo, J. I.
    Ribas, P.
    Jimenez, A.
    Gonzalez, J. D.
    Cejalvo, M. J.
    Solano, C.
    Alegre, A.
    de la Rubia, Javier
    ANNALS OF HEMATOLOGY, 2019, 98 (08) : 2013 - 2015
  • [6] Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma
    M. Blanes
    J. I. Lorenzo
    P. Ribas
    A. Jiménez
    J. D. González
    M. J. Cejalvo
    C. Solano
    A. Alegre
    Javier de la Rubia
    Annals of Hematology, 2019, 98 : 2013 - 2015
  • [7] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Miyamoto, Toshihiro
    Yoshimoto, Goichi
    Kamimura, Tomohiko
    Muta, Tsuyoshi
    Takashima, Shuichiro
    Ito, Yoshikiyo
    Shiratsuchi, Motoaki
    Choi, Ilseung
    Kato, Koji
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Takamatsu, Yasushi
    Teshima, Takanori
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (03) : 337 - 345
  • [8] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Toshihiro Miyamoto
    Goichi Yoshimoto
    Tomohiko Kamimura
    Tsuyoshi Muta
    Shuichiro Takashima
    Yoshikiyo Ito
    Motoaki Shiratsuchi
    Ilseung Choi
    Koji Kato
    Katsuto Takenaka
    Hiromi Iwasaki
    Yasushi Takamatsu
    Takanori Teshima
    Koichi Akashi
    International Journal of Hematology, 2013, 98 : 337 - 345
  • [9] HIGH-DOSE MELPHALAN IS A SAFE CONDITIONING REGIMEN IN ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Cangini, D.
    Cerchione, C.
    Giannini, M. B.
    Di Battista, V.
    Frabetti, F.
    Petracci, E.
    Ronconi, S.
    Martinelli, G.
    HAEMATOLOGICA, 2019, 104 : 163 - 163
  • [10] Bortezomib after high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with multiple myeloma: A comparison with the historical conditioning regimen with melphalan alone
    Ferini, G. A.
    Arbelbide, J. A.
    Basquiera, A. L.
    Nucifora, E.
    Schutz, N.
    Otero, V.
    Fantl, D.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S461 - S462
12345